| Issue Date | Title | Involved Person(s) |
| 14-Feb-2024 | Suicide rates and prescription of antidepressants | Amendola, Simone; Plöderl, Martin; Hengartner, Michael Pascal |
| 5-Aug-2023 | Observational studies of antidepressant use and suicide risk are selectively published in psychiatric journals | Plöderl, Martin; Amendola, Simone; Hengartner, Michael P. |
| 2022 | Increased suicide risk among younger women in winter during full moon in northern Europe : an artifact or a novel finding? | Plöderl, Martin; Westerlund, Joakim; Hökby, Sebastian; Hadlaczky, Gergö; Hengartner, Michael Pascal |
| 17-Dec-2021 | Effect of the FDA black box suicidality warnings for antidepressants on suicide rates in the USA : signal or noise? | Plöderl, Martin; Hengartner, Michael Pascal |
| 2021 | Suicidality and other severe psychiatric events with duloxetine : re-analysis of safety data from a placebo-controlled trial for juvenile fibromyalgia | Hengartner, Michael Pascal; Plöderl, Martin |
| 2021 | Prophylactic effects or withdrawal reactions? : an analysis of time-to-event data from antidepressant relapse prevention trials submitted to the FDA | Hengartner, Michael Pascal; Plöderl, Martin |
| 25-Nov-2020 | Did the introduction and increased prescribing of antidepressants lead to changes in long-term trends of suicide rates? | Amendola, Simone; Plöderl, Martin; Hengartner, Michael Pascal |
| 2020 | Efficacy of new-generation antidepressants assessed with the Montgomery-Asberg depression rating scale, the gold standard clinician rating scale : a meta-analysis of randomised placebo-controlled trials | Hengartner, Michael Pascal; Jakobsen, Janus C.; Sørensen, Anders; Plöderl, Martin |
| 24-Jun-2019 | Letter to the editor: newer-generation antidepressants and suicide risk in randomized controlled trials : a re-analysis of the FDA database | Hengartner, Michael Pascal; Plöderl, Martin |
| 2019 | What are the chances for personalised treatment with antidepressants? : detection of patient-by-treatment interaction with a variance ratio meta-analysis | Plöderl, Martin; Hengartner, Michael Pascal |
| 2019 | Guidelines for the pharmacological acute treatment of major depression : conflicts with current evidence as demonstrated with the German S3-guidelines | Plöderl, Martin; Hengartner, Michael Pascal |
| 2019 | Comment on Osler et al : misinterpretation of pre‐post‐differences invalidate the authors’ conclusions | Volkmann, Constantin; Plöderl, Martin; Hengartner, Michael Pascal |
| 2019 | Reply to the letter to the editor : “newer-generation antidepressants and suicide risk : thoughts on Hengartner and Plöderl’s re-analysis” | Hengartner, Michael Pascal; Plöderl, Martin |
| 2018 | Statistically significant antidepressant-placebo differences on subjective symptom-rating scales do not prove that the drugs work : effect Size and method bias matter! | Hengartner, Michael P.; Plöderl, Martin |
| 2018 | Antidepressant prescription rates and suicide attempt rates from 2004 to 2016 in a nationally representative sample of adolescents in the USA | Plöderl, Martin; Hengartner, Michael P. |
